Phathom Pharmaceuticals (PHAT) Q2 2026 Earnings

30AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.31
-0.97
-0.63
-0.29

Details

Expected EPS
-0.29048
Actual EPS
-0.37
Surprise EPS
-0.08
Surprise Percent
+27.38%

Description

Phathom Pharmaceuticals (PHAT) has reported earnings of -0.37 per share for Q2 2026.

0 Comments

Share your thoughts